HCA Healthcare, Inc.
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $75.6 billion, up 7.1% year-over-year |
| Net income attributable to HCA (FY2025) | $6.784 billion, up 17.8% year-over-year |
| Diluted EPS (FY2025) | $28.33, up from $22.00 in FY2024 |
| Adjusted EBITDA (FY2025) | $15.566 billion, roughly a 20.6% margin |
| Net income margin (FY2025) | Approximately 9.0% of revenue |
| Admissions (FY2025) | 2,297,065, up 2.7% year-over-year; same-facility equivalent admissions up 2.4% |
| Operating cash flow (FY2025) | $12.636 billion |
| Capital expenditures, excl. acquisitions (FY2025) | $4.944 billion |
| Hospitals operated | 190 hospitals plus roughly 2,500 sites of care, primarily in the U.S. and England |
| Employees (colleagues) | Approximately 316,000, per company disclosure |
| Local market position | Largest for-profit U.S. hospital operator; company reports an average ~27% share of the local markets it serves (target 29% by 2030), per HCA's December 2023 Investor Day as reported by Healthcare Dive |
Sources: Total revenue, net income, EPS, admissions and Adjusted EBITDA are from HCA Healthcare's Q4/full-year 2025 earnings release (Jan. 27, 2026). Revenue by geographic operating group (National, Atlantic, American, Corporate and other) is company-disclosed segment data compiled by Becker's Hospital Review from HCA's FY2025 filings; HCA does not publicly break out operating/net income by group, so no income pie is shown. The 'local market share' figure is HCA's own self-reported average share of the individual hospital markets in which it operates (not a national market share), disclosed at its December 2023 Investor Day and reported by Healthcare Dive; employee count is HCA's most recently widely-disclosed colleague headcount.